Cardiac manifestations in HIV patients and their correlation with CD4 count
DOI:
https://doi.org/10.18203/2349-3933.ijam20172272Keywords:
HIV, AIDS, CD4 count, Echocardiographic findingsAbstract
Background: The introduction of highly active antiretroviral therapy (HAART) has significantly improved the clinical evolution of human immunodeficiency virus (HIV)/AIDS disease, with an increased survival of infected patients. With advances in the management of patients living with HIV and AIDS, not only survival has increased but manifestations of late stage HIV infection are encountered more often including cardiovascular complications. Objectives were to determine the prevalence and characteristics of cardiac manifestations in patients with HIV infection, and to correlate the cardiac manifestations with CD4 count.
Methods: 115 HIV-positive cases and 30 healthy control subjects were evaluated by detailed history and general physical examination. CD4 was done for all patients using flowcytometry using a BD FACS Count system. All patients were evaluated using M Mode and two-dimensional transthoracic echocardiography and colour flow doppler examination.
Results: Male to female ratio was1.6:1in cases. The most common symptoms were cough (54.78%), palpitations (10%), shortness of breath (52%), chest pain on exertion (18.0%) and ankle swelling (21.0%). Echocardiographic abnormalities were found in 63% of the cases compared with 6% in the controls. 18 (15.65%) patients had dilated cardiomyopathy, 17 (15%) pericardial effusion, 16 (14%) pulmonary artery hypertension, 17 (15%) mitral valve prolapses and 25 (22%) had reduced ejection fraction compared with none of controls. 54 (47%) cases had diastolic dysfunction compared with 3 (10%) controls and 40 (35%) cases had reduced fractional shortening (≤27%) compared 4 (13%) controls. Significant statistical positive correlation was not observed between low CD4 count and echocardiographic abnormalities. Pericardial effusion was seen more in patients with CD4 count below 200.
Conclusions: Cardiovascular abnormalities in HIV infected patients are common and can occur without any clinical manifestation. There was no significant association between CD4 count and any cardiac manifestation.
References
Steinbrook R. HIV in India- a downsized epidemic New Engl J Med. 2008;358:107-9.
Barbarini G, Barbaro G. Incidence of the involvement of the cardiovascular system in HIV infection. AIDS. 2003;17:46-50.
Barbaro G, Di Lorenzo G, Grisorio B. Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. AIDS Res Hum Retroviruses. 1998;14:1071-7.
Patel K, Van Dyke RB, Mittleman MA. International Maternal Pediatric Adolescent AIDS Clinical Trials 219219C Study Team. The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1. AIDS. 2012;16:2027-37.
Stewart JM, Kaul A, Gromisch DS. Symptomatic cardiac dysfunction in children with human immunodeficiency virus infection. Am Heart J. 1989;117(1):140-4.
Fisher SD, Easley KA, Orav EJ. Pediatric pulmonary and cardio-vascular complications of vertically transmitted HIV Infection study group. Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter study. Am Heart J. 2005;150(3):439-47.
Longo-Mbenza B, Seghers KV, Phuati M. Heart involvement and HIV infection in African patients: determinants of survival. Int J Cardiol. 1998;64(1):63-73.
Friis-Moller N, Sabin CA, Weber R. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993-2003.
Arminio A, Sabin CA, Phillips AN. Cardio and cerebrovascular events in HIV-infected persons. AIDS. 2004;18:1811-7.
Gottdiener JS, Bednarz J, Devereux R. American Society of Echocardiography recommendations for use of echocardiography in clinical trials: A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Task Force on Echocardiography in Clinical Trials. J Am Soc Echocardiogr. 2004;17:1086-119.
Feigenbaum H. Echocardiography. Philadelphia: Lippincott William and Wilkins; 2005:138-180.
Henry WL, De Maria A, Gramiak R. Report of the American Society of Echocardiography committee on nomenclature and standards in 2-D echocardiography. Circulation. 1980;62:212-7.
Cardoso JS, Miranda AM, Moura B. Cardiac morbidity in the human immunodeficiency virus infection. Rev Port Cardiol. 1994;13:901-11.
Herskowitz A, Vlahov D, Willoughby S, Chaisson RE, Schulman SP, Neumann DA, et al. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. American J Cardiol. 1993;71(11):955-8.
Jain N, Reddy DH, Verma SP, Khanna R, Vaish AK, Usman K, et al. Cardiac abnormalities in HIV-positive patients: results from an observational study in India. J Int Assoc Providers AIDS Care. (JIAPAC). 2014;13(1):40-6.
Wu TC, Pizzorno MC, Hayward GS. In situ detection of human cytomegalovirus immediate-early gene transcripts within cardiac myocytes of patients with HIV-associated cardiomyopathy. AIDS. 1992;6:777-85.
Mirri A, Rapezzi C, Iacopi F, Ortolani P, Binetti G, Fabbri M, et al. Cardiac involvement in HIV infection: a prospective, multicenter clinical and echocardiographic study. Cardiologia. 1990;35(3):203-9.
Nzuobontane D, Blackett KN, Kuaban C. Cardiac Involvement in HIV infected people in Yaounde Cameroon. Postgrad Med J. 2002;78:678-81.
Longo-Mbenza B, Seghers KV, Phuati M. Heart involvement and HIV infection in African patients: determinants of survival. Int J Cardiol. 1998;64(1):63-73.
Corallo S, Mutinelli MR, Momoi M. Echocardiography detects myocardial damage in AIDS: prospective study in 102 patients. Eur Heart J. 1988;9:887-92.
Ntsekhe M, Hakim J. Impact of human immunodeficiency virus infection on cardiovascular disease in Africa. Circulation. 2005;112:3602-7.
Barbaro G, Lorenzo G, Grisorio B. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV positive patients. N Engl J Med. 1998;339:1093-9.
Barbaro G, Di Lorenzo G, Soldini M. The intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Circulation. 1999;100:633-9.
Lipshultz SE. Dilated cardiomyopathy in HIV-infected patients. N Engl J Med. 1998;339:1153-5.
Moreno R, Villacastin JP, Bueno H. Clinical and echocardiographic findings in HIV Patients with pericardial effusion. Cardiology. 1997;88:397-400.
Hakim JG, Matenga JA, Siziya S. Myocardial dysfunction in HIV infection: an echocardiographic study of 157 patients in hospital in Zimbabwe. Heart. 1996;76:161-5.
Aggarwal P, Sharma A, Bhardwaj R. Myocardial dysfunction in human immunodeficiency virus infection: an echocardiographic study. J Assoc Physic India. 2009;57:745-6.
Himelman RB, Chung WS, Chernoff DN, Schiller NB, Hollander H. Cardiac manifestations of human immunodeficiency virus infection: a two-dimensional echocardiographic study. J Am Coll Cardiol. 1989;13(5):1030-6.
